Skip to main content
CELADON PHARMACEUTICALS PLC logo

CELADON PHARMACEUTICALS PLC — Investor Relations & Filings

Ticker · CEL ISIN · GB00BDQYGP38 LEI · 213800YXCATORT475807 IL Manufacturing
Open in API
Filings indexed 128 across all filing types
Latest filing 2023-01-19 Regulatory Filings
Country GB United Kingdom
Listing IL CEL

About CELADON PHARMACEUTICALS PLC

https://celadonpharma.co.uk/

Celadon Pharmaceuticals PLC is a vertically integrated pharmaceutical company focused on the research, cultivation, manufacturing, and supply of cannabinoid-based medicines. The company operates a licensed, 100,000 sq ft facility with EU-GMP certification for the indoor, hydroponic cultivation of high-THC cannabis and the extraction of cannabinoid Active Pharmaceutical Ingredients (API). Its primary focus is the chronic pain market, and it is conducting an MHRA conditionally approved clinical trial to generate data supporting the use of its medicines for this condition. Additionally, Celadon has an in-house research and development program focused on intellectual property generation and is involved in developing a licensed cannabinoid treatment for Autism Spectrum Disorder through a biopharma partnership.

Recent filings

Filing Released Lang Actions
Change of Website Address
Regulatory Filings Classification · 98% confidence The document is very short (2900 characters) and its primary purpose is to announce a 'Change of Website Address' for Celadon Pharmaceuticals Plc, referencing the RNS Number and the London Stock Exchange's RNS service. It does not contain detailed financial results (ruling out ER, IR, 10-K), management changes (ruling out MANG), or specific voting information. Since it is a general, non-specific regulatory announcement distributed via the RNS system, and it doesn't fit neatly into the other specific categories like DIV, CAP, or DIRS, the most appropriate classification is the general regulatory filing fallback category.
2023-01-19 English
Approval of GMP Registration by MHRA
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated January 16, 2023. It announces a specific corporate event: 'Approval of GMP Registration by MHRA' for Celadon Pharmaceuticals Plc. The text details operational achievements (GMP registration, global standing, future supply plans) and includes executive commentary and contact information typical of a formal market announcement. The presence of the RNS header and the nature of the announcement (a significant operational milestone) strongly suggest this is a regulatory news service release. Since it is a general, material announcement that doesn't fit the specific categories like Earnings Release (ER), Director's Dealing (DIRS), or Capital Change (CAP), the most appropriate classification is the general regulatory filing category, RNS.
2023-01-16 English
Update on CFO Appointment
Board/Management Information Classification · 99% confidence The document is identified by the header 'RNS Number : 5970M' and contains information about a formal appointment of a Chief Financial Officer (CFO), Jonathan Turner, effective January 17, 2023. This type of announcement, detailing changes in senior management, directly corresponds to the 'Board/Management Information' definition. The document is short and appears to be a formal regulatory news service release (RNS), but the core content is management change, making MANG the most specific fit over the general RNS fallback.
2023-01-13 English
Results of Feasibility Study
Regulatory Filings Classification · 98% confidence The document is clearly identified as an 'RNS Number' announcement from the London Stock Exchange, which is a primary indicator of a regulatory filing. The content announces the submission of feasibility study results to a Research Ethics Committee (REC) and references previous announcements and regulatory bodies (MHRA). This type of immediate, material, non-periodic corporate update that is distributed via the RNS system fits best under the general 'Regulatory Filings' category, as it is not a full report (10-K, IR), an earnings release (ER), or a specific management/director transaction (MANG, DIRS). Given the nature of the announcement (a specific operational update distributed via the official regulatory news service), RNS is the most appropriate classification, acting as the catch-all for such immediate disclosures.
2022-12-30 English
Update on GMP Registration by MHRA
Regulatory Filings Classification · 100% confidence The document is identified by the header 'RNS Number : 5392K' and contains standard boilerplate language indicating it is a regulatory announcement distributed by RNS, the news service of the London Stock Exchange, which is approved by the FCA as a Primary Information Provider. The content provides an 'Update on GMP Registration by MHRA' and references previous announcements ('Interim results announced on 29 September 2022'). This type of operational or regulatory update that does not fit into specific financial reporting categories (like 10-K, ER, IR) or specific corporate actions (like DIV, CAP) is best classified under the general regulatory announcement category. Given the presence of the RNS distribution information and the nature of the update (regulatory progress), the most appropriate classification is Regulatory Filings (RNS). It is not a full report (like 10-K or IR), nor is it a specific announcement like a dividend or management change.
2022-12-22 English
Appointment of CFO
Board/Management Information Classification · 98% confidence The document is a formal announcement released via RNS (Regulatory News Service) on November 1, 2022. The core content is the 'Appointment of CFO' (Chief Financial Officer), detailing the incoming and outgoing executive personnel, including required disclosures under AIM Rules regarding directorships and past company involvement. This type of announcement, concerning changes in senior management, directly corresponds to the definition of Board/Management Information (MANG). Although it is distributed via RNS, the specific subject matter is management change, making MANG the most precise classification.
2022-11-01 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.